Venous Sinus Stenting for Idiopathic Intracranial Hypertension: Impact on Headache-Specific Quality of Life Scores

Venous sinus stenting (VSS) for treatment of idiopathic intracranial hypertension (IIH) has emerged as a viable alternative treatment to traditional surgical interventions. Headache, the most common symptom in IIH, may persist after the resolution of papilledema consistent with successful treatment response. Formal assessment of headache impact on quality of life (QOL) by questionnaireprovides valuable information and better understanding for patients and doctors regarding treatment progress and outcome. We assessed headache-specific QOL (HQOL) scores and CSF opening pressure (OP) before and after VSS. We hypothesized that postoperative improvement in HQOL scores would correlate with improvement in CSF-OP.